Brooke Army Medical Center — Fort Sam Houston, Texas

Public research footprint of Brooke Army Medical Center, compiled from the ClinicalTrials.gov public registry.

345

Registered studies

Active

Recruiting now

237

Completed

Stopped or withdrawn

Most-studied conditions

Stage IB Lung Non-Small Cell Carcinoma AJCC v7 · Stage IIIA Lung Non-Small Cell Cancer AJCC v7 · Stage III Kidney Wilms Tumor · Traumatic Wounds and Injuries

Recently updated registry entries

NCT01274338 — Ipilimumab or High-Dose Interferon Alfa-2b in Treating Patients With High-Risk Stage… (Active Not Recruiting)
NCT00310180 — Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have… (Active Not Recruiting)
NCT02194738 — Genetic Testing in Screening Patients With Stage IB-IIIA Non-small Cell Lung Cancer That… (Active Not Recruiting)

7 more recent registry entries at this facility

Enter your work email to view the full list.

I’d also like to receive occasional marketing emails from Eichor for research sites (optional — unsubscribe anytime).

Work at Brooke Army Medical Center?

Verify and correct how your facility appears in public registry records — free.

Verify this profile →

Compiled from public registry records (ClinicalTrials.gov) as of August 02, 2026. Counts reflect how this facility appears in registry listings; name variants may exist and are not combined. This page describes public records only and makes no assessment of any facility.